Clin2
NCT06647745Possibly a fitRecruiting

Study for type 2 diabetes and high blood pressure

Type 2 DiabetesHypertension

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study tests a new combination of three medications (THP-00101, THP-00102, and THP-00103) for people with type 2 diabetes and essential high blood pressure. It aims to see if this combination is safe and effective compared to standard treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
221 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years of age or older.
  • You have both type 2 diabetes and essential high blood pressure.
  • Your blood sugar control (HbA1c) is between 6.5% and 9.5%, and your fasting blood sugar is 270 mg/dL or lower.
  • Your blood pressure is high but not extremely high (between 130-160 mmHg systolic, depending on whether you take blood pressure medicine).
  • You are able to stop taking your current diabetes and blood pressure medicines (except for metformin) during the study.
  • You have not had certain medical conditions like severe heart, kidney, or liver problems, recent surgeries, or infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07552389Recruiting· Phase 3
Blood Pressure and Diabetes Combination Drug Trial

This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.

Seoul
NCT07660796Not yet recruiting· Phase 3
New blood pressure medicine for people with high blood pressure

This study tests a new combination blood pressure medicine (HCP1803-4) for people with essential hypertension. It aims to see if the medicine works better than current options and is safe for long-term use.

Goyang-si, Gyeonggi-do
NCT07546929Recruiting· Phase 2
HP-211 Safety Study for Type 2 Diabetes Treatment

This study tests a new medicine called HP-211 in people with early-stage type 2 diabetes to see if it's safe and helps control blood sugar. You'd take the study drug along with your current diabetes management.

Canoga Park, California
NCT07568678Recruiting· Phase 1
Testing HMS1005 in adults with type 2 diabetes

This study tests a new medicine called HMS1005 in people with type 2 diabetes. Researchers want to see how safe it is and how the body responds to different doses. You may qualify if you have type 2 diabetes that is either untreated or controlled with common diabetes medications.

Miami, Florida
NCT06790927Not yet recruiting
Standardized blood pressure treatment study

This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.

Shanghai, China
NCT07579260Not yet recruiting
Impact of high blood pressure treatments study (IMPACT-HTN)

This study tests how well a combination of blood pressure medications works for people whose blood pressure is still high despite taking two or more medicines. It involves reporting your blood pressure monthly by answering survey questions.

Palo Alto, California

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.